Berger_2023_Front.Endocrinol.(Lausanne)_14_1092024

Reference

Title : Inhibition of diacylglycerol lipase beta modulates lipid and endocannabinoid levels in the ex vivo human placenta - Berger_2023_Front.Endocrinol.(Lausanne)_14_1092024
Author(s) : Berger N , van der Wel T , Hirschmugl B , Baernthaler T , Gindlhuber J , Fawzy N , Eichmann T , Birner-Gruenberger R , Zimmermann R , van der Stelt M , Wadsack C
Ref : Front Endocrinol (Lausanne) , 14 :1092024 , 2023
Abstract : Berger_2023_Front.Endocrinol.(Lausanne)_14_1092024
ESTHER : Berger_2023_Front.Endocrinol.(Lausanne)_14_1092024
PubMedSearch : Berger_2023_Front.Endocrinol.(Lausanne)_14_1092024
PubMedID: 36864832
Gene_locus related to this paper: human-DAGLA , human-DAGLB

Related information

Gene_locus related to this paper: human-DAGLA , human-DAGLB

Citations formats

Berger N, van der Wel T, Hirschmugl B, Baernthaler T, Gindlhuber J, Fawzy N, Eichmann T, Birner-Gruenberger R, Zimmermann R, van der Stelt M, Wadsack C (2023)
Inhibition of diacylglycerol lipase beta modulates lipid and endocannabinoid levels in the ex vivo human placenta
Front Endocrinol (Lausanne) 14 :1092024

Berger N, van der Wel T, Hirschmugl B, Baernthaler T, Gindlhuber J, Fawzy N, Eichmann T, Birner-Gruenberger R, Zimmermann R, van der Stelt M, Wadsack C (2023)
Front Endocrinol (Lausanne) 14 :1092024